jesse_the_k + depression   9

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. - PubMed - NCBI
J Affect Disord. 2017 Jan 15;208:6-14. doi: 10.1016/j.jad.2016.08.029. Epub 2016 Oct 1.
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.
ldn  low-dose-Naltrexone  results  clinical-trial  depression 
march 2017 by jesse_the_k
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. - PubMed - NCBI
J Affect Disord. 2017 Jan 15;208:6-14. doi: 10.1016/j.jad.2016.08.029. Epub 2016 Oct 1.
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.
Mischoulon D1, Hylek L2, Yeung AS2, Clain AJ2, Baer L2, Cusin C2, Ionescu DF2, Alpert JE2, Soskin DP2, Fava M2.
Author information
ldn  low-dose-Naltrexone  clinical-trial  results  depression 
march 2017 by jesse_the_k

Copy this bookmark:



description:


tags: